Davin Tjoputro - Suparma Tbk Head Audit
| SPMA Stock | IDR 296.00 2.00 0.67% |
Insider
Davin Tjoputro is Head Audit of Suparma Tbk
| Phone | 62 31 766 6666 |
| Web | https://www.ptsuparmatbk.com |
Suparma Tbk Management Efficiency
The company has return on total asset (ROA) of 0.1105 % which means that it generated a profit of $0.1105 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1881 %, meaning that it generated $0.1881 on every $100 dollars invested by stockholders. Suparma Tbk's management efficiency ratios could be used to measure how well Suparma Tbk manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| SEAs AAAIK | Asuransi Harta Aman | 58 | |
| Melly Elita | PT Kusuma Kemindo | 54 | |
| Natalia Lusnita | Mitra Pinasthika Mustika | N/A | |
| Edy Jonathan | Capital Financial Indonesia | 55 | |
| Indar Dhaliwal | Indosat Tbk | 35 | |
| Efrizal | Bank Negara Indonesia | 52 | |
| Muhammad Iqbal | Bank Negara Indonesia | 50 | |
| Didik Riyadi | Timah Persero Tbk | N/A | |
| Johansyah | Bank Negara Indonesia | 41 | |
| Edhi Sebayang | Capital Financial Indonesia | 39 | |
| Muhamad Fathany | Capital Financial Indonesia | 52 | |
| Rinawati | Asuransi Harta Aman | 48 | |
| Vikram Sinha | Indosat Tbk | 48 | |
| Rahman Kurniawan | Semen Indonesia Persero | N/A | |
| Treesje Halim | Asuransi Harta Aman | 53 | |
| Yohan Setio | Bank Negara Indonesia | 36 | |
| Susan Ong | Mitra Pinasthika Mustika | N/A | |
| Ario Bimo | Bank Negara Indonesia | 38 | |
| Desmond Cheung | Indosat Tbk | N/A | |
| Devin B | Indosterling Technomedia Tbk | 25 | |
| Chi Lee | Indosat Tbk | N/A | |
Management Performance
| Return On Equity | 0.19 | |||
| Return On Asset | 0.11 |
Suparma Tbk Leadership Team
Elected by the shareholders, the Suparma Tbk's board of directors comprises two types of representatives: Suparma Tbk inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Suparma. The board's role is to monitor Suparma Tbk's management team and ensure that shareholders' interests are well served. Suparma Tbk's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Suparma Tbk's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alberta Angela, Co Sec | ||
| Edward Sopanan, Pres Director | ||
| Davin Tjoputro, Head Audit | ||
| Hendro Luhur, Director, Corporate Secretary |
Suparma Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Suparma Tbk a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 1.45 T | |||
| Shares Outstanding | 3.15 B | |||
| Shares Owned By Insiders | 92.37 % | |||
| Price To Earning | 3.91 X | |||
| Price To Sales | 0.50 X | |||
| Revenue | 2.79 T |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Suparma Stock
Suparma Tbk financial ratios help investors to determine whether Suparma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Suparma with respect to the benefits of owning Suparma Tbk security.